Indian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United States and China. However, other markets like Africa and Oceania showed strong growth. Vaccines emerged as the fastest-growing export category. The industry is navigating challenges in key markets while exploring new growth avenues.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Cm9AgZw
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Pharma exports surpass $31 billion in FY26 despite global headwinds






0 comments:
Post a Comment